Denali Therapeutics
DNLI
#3762
Rank
NZ$5.71 B
Marketcap
NZ$36.06
Share price
0.56%
Change (1 day)
37.35%
Change (1 year)

Market capitalization of Denali Therapeutics (DNLI)

Market cap: NZ$5.71 Billion

As of March 2026 Denali Therapeutics has a market cap of NZ$5.71 Billion. This makes Denali Therapeutics the world's 3762th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Denali Therapeutics from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$5.71 B25.71%
2025NZ$4.54 B-13.51%
2024NZ$5.25 B12.15%
2023NZ$4.68 B-21.17%
2022NZ$5.94 B-25.4%
2021NZ$7.97 B-42.72%
2020NZ$13.92 B459.51%
2019NZ$2.48 B-14.67%
2018NZ$2.91 B50.49%
2017NZ$1.93 B

End of Day market cap according to different sources

On Mar 10th, 2026 the market cap of Denali Therapeutics was reported to be:

NZ$5.71 Billion
by Nasdaq info icon info icon
NZ$5.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Organovo
ONVO
NZ$6.17 M-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
NZ$0.63 B-88.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ$2.93 B-48.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
NZ$2.44 B-57.31% Jersey